Estrogen Receptor: A Paradigm for Targeted Therapy.

Area of Science:

• Oncology
• Endocrinology
• Molecular Biology

Background:

• Estrogen receptors (ERs) are overexpressed in nearly two-thirds of breast cancers.
• Endocrine therapy targeting ERs is a cornerstone of systemic treatment for early and advanced breast cancer.
• Significant advancements in ER biology have profoundly impacted patient survival and treatment strategies.

Purpose of the Study:

• To revisit the landmark 1977 article by Knight et al. in Cancer Research.
• To highlight key breakthroughs in estrogen receptor biology over the past century.
• To underscore the importance of ER targeting in breast cancer prognostication and treatment selection.

Main Methods:

• Commentary and historical review of seminal research in estrogen receptor biology.
• Analysis of the impact of the Knight et al. study on clinical practice.
• Synthesis of over a century of advancements in understanding estrogen receptor function.

Main Results:

• The 1977 study by Knight et al. provided foundational insights for ER prognostication and adjuvant treatment selection.
• Estrogen receptor targeting has become a highly impactful therapeutic strategy in oncology.
• Decades of research have solidified the role of ERs in breast cancer management and survival outcomes.

Conclusions:

• Estrogen receptor research has been pivotal in advancing breast cancer therapy.
• Targeting estrogen receptors remains a critical component of effective breast cancer treatment.
• Continued exploration of ER biology promises further improvements in patient care and outcomes.